netFormulary
 Report : A-Z HCD items in Formulary 12/04/2021 00:56:37
[Back]
 
Section Status Black Triangle Name
08.01.05 Formulary Black Triangle Abemaciclib Verzenios
08.01.05 Formulary Black Triangle Acalabrutinib Calquence®
08.01.05 Formulary Black Triangle Afatinib Giotrif
08.01.05 Formulary Black Triangle Alectinib Alecensa
08.01.05 Formulary Black Triangle Atezolizumab Tecentriq
08.01.05 Formulary Black Triangle Avelumab Bavencio
08.01.05 Restricted Use Black Triangle Axicabtagene ciloleucel YESCARTA
08.01.05 Formulary Black Triangle Binimetinib Mektovi
08.01.05 Non Formulary Black Triangle Bosutinib Bosulif
08.01.05 Formulary Black Triangle Bosutinib Bosulif
08.01.05 Formulary Black Triangle Brentuximab vedotin Adcetris
08.01.05 Formulary Black Triangle Brigatinib Alunbrig
11.08.02 Formulary Black Triangle Brolucizumab Beovu ,Novartis
08.01.05 Non Formulary Black Triangle Cabozantinib Cometriq
08.01.05 Formulary Black Triangle Cabozantinib Cometriq, Cabometyx
08.01.05 Formulary Black Triangle Ceritinib Zykadia
08.01.05 Formulary Black Triangle Crizotinib Xalkori
08.01.05 Formulary Black Triangle Dabrafenib Tafinlar
08.01.05 Non Formulary Black Triangle Dabrafenib Tafinlar
05.03.03.02 Formulary Black Triangle Daclatasvir Daklinza
08.01.05 Non Formulary Black Triangle Daratumumab DARZALEX
08.01.05 Formulary Black Triangle Daratumumab DARZALEX
05.03.03.02 Formulary Black Triangle Dasabuvir Exviera
08.01.05 Restricted Use Black Triangle Dinumtuximab Qarziba
13.05.03 Formulary Black Triangle Dupilumab Dupixent
08.01.05 Formulary Black Triangle Durvalumab Imfinzi
05.03.03.02 Formulary Black Triangle Elbasvir with Grazoprevir Zepatier
02.11 Restricted Use Black Triangle Emicizumab Hemlibra
08.01.05 Formulary Black Triangle Encorafenib Braftovi
08.01.05 Formulary Black Triangle Entrectinib Rozlytrek
04.07.04.02 Formulary Black Triangle Galcanezumab Emgality
08.01.05 Formulary Black Triangle Gemtuzumab ozogamicin MYLOTARG
08.01.05 Formulary Black Triangle Gilteritinib Xospata
05.03.03.02 Formulary Black Triangle Glecaprevir with Pibrentasvir Maviret
08.01.05 Formulary Black Triangle Idelalisib Zydelig
08.01.05 Non Formulary Black Triangle Idelalisib Zydelig
08.01.05 Formulary Black Triangle Inotuzumab ozogamicin BESPONSA
08.01.05 Formulary Black Triangle Isatuximab Sarclisa
05.02.01 Restricted Use Black Triangle Isavuconazole CRESEMBA
03.12 Formulary Black Triangle Ivacaftor/Tezacaftor/Elexacaftor Kaftrio
08.01.05 Formulary Black Triangle Ixazomib Ninlaro
08.01.05 Restricted Use Black Triangle Larotrectinib Vitrakvi®
08.01.05 Formulary Black Triangle Lenvatinib Kisplyx, Lenvima
08.01.05 Restricted Use Black Triangle Lorlatinib Lorviqua
08.01.05 Formulary Black Triangle Lutetium (177Lu) oxodotreotide Lutathera
14.04 Formulary Black Triangle Meningococcal group B Vaccine Bexsero
15.01.02 Formulary Black Triangle Methoxyflurane Penthrox®
08.01.05 Formulary Black Triangle Midostaurin Rydapt
08.01.05 Formulary Black Triangle Nintedanib  Vargatef, Ofev
08.01.05 Formulary Black Triangle Niraparib Zejula
08.01.05 Non Formulary Black Triangle Nivolumab Opdivo
08.01.05 Formulary Black Triangle Nivolumab Opdivo
08.02.03 Formulary Black Triangle Obinutuzumab  Gazyvaro
08.02.04 Formulary Black Triangle Ocrelizumab OCREVUS
08.01.05 Non Formulary Black Triangle Olaratumab Lartruvo
05.03.03.02 Formulary Black Triangle Ombitasvir with Paritaprevir and Ritonavir Viekirax
08.01.05 Formulary Black Triangle Osimertinib Tagrisso
08.01.05 Non Formulary Black Triangle Padeliporfin TOOKAD
08.01.05 Formulary Black Triangle Palbociclib IBRANCE
09.02.01.01 Formulary Black Triangle Patiromer Sorbitex Calcium Veltassa
08.01.05 Formulary Black Triangle Pembrolizumab Keytruda
08.01.05 Formulary Black Triangle Pemigatinib Pemazyre
08.01.05 Formulary Black Triangle Polatuzumab vedotin Polivy
08.01.05 Formulary Black Triangle Ponatinib Iclusig
08.01.05 Formulary Black Triangle Regorafenib Stivarga
05.03 Restricted Use Black Triangle Remdesivir Veklury (r)
08.01.05 Formulary Black Triangle Ribociclib Kisqali
09.02.01.01 Formulary Black Triangle sodium zirconium cyclosilicate Lokelma
05.03.03.02 Formulary Black Triangle Sofosbuvir Sovaldi
05.03.03.02 Formulary Black Triangle Sofosbuvir with ledipasvir Harvoni
05.03.03.02 Formulary Black Triangle Sofosbuvir with velpatasvir Epclusa
05.03.03.02 Formulary Black Triangle Sofosbuvir with Velpatasvir and Voxilaprevir Vosevi
01.09 Formulary Black Triangle Telotristat Xermelo
08.01.05 Restricted Use Black Triangle Tisagenlecleucel Kymriah
08.01.05 Formulary Black Triangle Tivozanib Fotivda
08.01.05 Formulary Black Triangle Trametinib Mekinist
08.01.05 Non Formulary Black Triangle Trametinib Mekinist
08.01.05 Formulary Black Triangle Trastuzumab emtansine Kadcyla
10.01.03 Formulary Black Triangle Upadacitinib Rinvoq
08.01.05 Non Formulary Black Triangle Vandetanib Caprelsa
08.01.05 Formulary Black Triangle Venetoclax Venclyxto
08.01.05 Non Formulary Black Triangle Vismodegib Erivedge
02.11 Formulary Black Triangle Vonicog alfa Veyvondi®
Dorset